Report Company Directory

ENNORE COKE LIMITED

ENNOSTAR

• ENNOSTAR (3714 TT) (Neutral) - Progress continues in auto and micro LED in 2025 by Nomura Research
• Global Tech Strategy - Tech Weekly: Tech opportunities as AI broadens by Nomura Research
• Quick Note - ENNOSTAR (3714 TT) (Neutral) - Still a transition year in 2024 by Nomura Research
• Anchor Report: Asia Pacific Technology - 2024 outlook: Cyclical upswing, secular AI driver by Nomura Research
• Global Tech Strategy - Tech Weekly: Clear turn upwards in chip cycle graphs by Nomura Research
• ENNOSTAR (3714 TT) (Neutral) - 2Q23 losses decline, but muted 3Q recovery likely by Nomura Research
• Global Tech Strategy - Tech Weekly: Market bottom holding, up-cycle starting? by Nomura Research
• Global Tech Strategy - Tech Weekly: Signs of approaching tech bottom by Nomura Research
• ENNOSTAR (3714 TT) (Neutral) - Headwinds from mini LED outweigh other drivers by Nomura Research
• Global Tech Strategy - Tech Weekly: Early signs of inventory bottoming by Nomura Research

Ennox Group

• Ford Equity International Rating and Forecast Report by Ford Equity Research

Enochian Biosciences

• Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform by GlobeNewsWire
• UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology by GlobeNewsWire
• Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology by GlobeNewsWire
• Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform by GlobeNewsWire
• Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics by GlobeNewsWire
• Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs by GlobeNewsWire
• Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine by GlobeNewsWire
• Renovaro Provides Update to Definitive Agreement with Predictive Oncology by GlobeNewsWire
• Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology by GlobeNewsWire
• Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine by GlobeNewsWire

Enomoto Co. Ltd.

• Ford Equity International Rating and Forecast Report by Ford Equity Research